磁共振引导激光消融治疗深部脑海绵状血管瘤的可行性与并发症:4例报告
本文回顾性分析4例接受磁共振引导激光间质热疗(MRgLITT)的症状性深部脑海绵状血管瘤(CCM)患者,病灶位于丘脑、壳核、中脑或底丘脑。所有患者随访中病灶体积减少20%至73%,但出现设备故障致盐水泄漏暂时占位效应、无症状性针道出血及一例基线缺损轻度持续加重。作者认为MRgLITT对深部CCM可行,但可能并发症风险高且无确定性切除获益,建议谨慎选择患者、低激光功率和保守温度监测。
要点
- MRgLITT可用于症状性深部CCM,随访病灶体积减少20%至73%。
- 并发症包括设备故障致盐水泄漏暂时占位效应和无症状性针道出血。
- 一例患者出现预期轻度但持续的基线缺损加重。
核心结论
- MRgLITT治疗症状性深部CCM可行,但可能并发症风险高且无确定性切除获益。
研究设计与样本
- 回顾性病历复习,4例症状性深部CCM患者接受MRgLITT,使用商用系统在介入MRI手术室进行。
主要发现
- 4例患者CCM位于丘脑、壳核、中脑或底丘脑,均表现为持续致残性神经症状。
- 2例表现为致残性头痛和感觉障碍,2例为复发性症状性出血,其中1例为家族性CCM。
- 血管神经外科医生认为患者不适合开放手术或患者拒绝开放手术。
- 多数病例使用多轨迹。
- 不良事件包括1例设备故障盐水泄漏导致暂时占位效应,1例无症状性针道出血,1例预期轻度但持续基线缺损加重。
临床怎么用
- 对症状性深部CCM可考虑MRgLITT,但需谨慎选择患者。
- 建议使用低激光功率设置。
- 建议对周围脑实质进行保守的温度监测。
局限性
- 回顾性研究,样本量仅4例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Magnetic resonance imaging (MRI)-guided laser interstitial thermal therapy (MRgLITT) has been used successfully to treat epileptogenic cortical cerebral cavernous malformations (CCM). It is unclear whether MRgLITT would be as feasible or safe for deep CCMs. OBJECTIVE: To describe our experience with MRgLITT for symptomatic deep CCMs. METHODS: Patients' records were reviewed retrospectively. MRgLITT was carried out using a commercially available system in an interventional MRI suite with efforts to protect adjacent brain structures. Immediate postoperative imaging was used to judge ablation adequacy. Delayed postoperative MRI was used to measure lesion volume changes during follow-up. RESULTS: Four patients with CCM in the thalamus, putamen, midbrain, or subthalamus presented with persistent and disabling neurological symptoms. A total of 2 patients presented with disabling headaches and sensory disturbances and 2 with recurrent symptomatic hemorrhages, of which 1 had familial CCM. Patients were considered by vascular neurosurgeons to be poor candidates for open surgery or had refused it. Multiple trajectories were used in most cases. Adverse events included device malfunction with leakage of saline causing transient mass effect in one patient, and asymptomatic tract hemorrhage in another. One patient suffered an expected mild but persistent exacerbation of baseline deficits. All patients showed improvement from a previously aggressive clinical course with lesion volume decreased by 20% to 73% in follow-up. CONCLUSION: MRgLITT is feasible in the treatment of symptomatic deep CCM but may carry a high risk of complications without the benefit of definitive resection. We recommend cautious patient selection, low laser power settings, and conservative temperature monitoring in surrounding brain parenchyma.
引用
- Malcolm JG, Douglas JM, Greven A, et al. Feasibility and Morbidity of Magnetic Resonance Imaging-Guided Stereotactic Laser Ablation of Deep Cerebral Cavernous Malformations: A Report of 4 Cases. Neurosurgery. 2021. PMID: 34270738. doi:10.1093/neuros/nyab241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。